VaxGen: HHS Anthrax Vaccine Delay Threatens Company

Drug Industry Daily
KEYWORDS HHS / Pricing
A A

Delivery to the federal government of the anthrax vaccine being developed by VaxGen, originally expected to occur by the end of the year, now will be pushed until at least late 2007, delivering a heavy fiscal blow to the financially struggling company, a VaxGen spokesman said.

To View This Article:

Login

Subscribe To Drug Industry Daily